Despite having little experience relevant to the industry, Samsung is confident it can take on the global pharmaceutical market, which is expected to grow up to $278 billion by 2020.

from Forbes – Tech http://www.forbes.com/sites/johnkang/2016/11/09/samsungs-next-cash-cow-could-be-this-8b-contract-drugmaker/
via IFTTT